LFVN Lifevantage

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against LifeVantage Corporation - LFVN

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of LifeVantage Corporation (NASDAQ: LFVN) resulting from allegations that LifeVantage may have issued materially misleading business information to the investing public.

On September 13, 2016, LifeVantage disclosed that it was delaying the release of its fourth quarter and fiscal year 2016 financial results. The delay is due to LifeVantage’s review of its sales into certain international markets and the revenue and income tax and the associated accruals. On this news, shares of LifeVantage fell sharply during intraday trading on September 14, 2016.

Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by LifeVantage investors. If you purchased shares of LifeVantage on or before September 13, 2016, please visit the firm’s website at http://www.rosenlegal.com/cases-952.html for more information. You may also contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.

EN
14/09/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Lifevantage

 PRESS RELEASE

LifeVantage Declares Quarterly Dividend

LifeVantage Declares Quarterly Dividend SALT LAKE CITY, May 06, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of $0.045 per share of common stock, which will be paid June 13, 2025 to all stockholders of record at the close of business on May 30, 2025. This represents an increase in the dividend amount by 12.5% over the previous quarter. About LifeVantage Corpo...

 PRESS RELEASE

LifeVantage Announces Financial Results for the Third Quarter of Fisca...

LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2025 SALT LAKE CITY, May 06, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2025. Third Quarter Fiscal 2025 Summary*: Revenue was $58.4 million, an increase of 21.1% from the prior year period. Excluding the negative impact of foreign currency fluctuations, third quarter revenue increased approximat...

 PRESS RELEASE

Global Convention 2025 Empowers Consultants to ‘Go Further’ with Exclu...

Global Convention 2025 Empowers Consultants to ‘Go Further’ with Exclusive Trainings, Product Announcements, and New Incentives to Drive Growth Convention hosted in Salt Lake City, Utah April 24-26, attended by over 2,000 Independent Consultants from around the world SALT LAKE CITY, April 28, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the successful conclusion of their annual Global Convention, held April 24-26, 2025, in Salt Lake City, Utah. Thousands ...

 PRESS RELEASE

LifeVantage to Announce Third Quarter Fiscal Year 2025 Results on May ...

LifeVantage to Announce Third Quarter Fiscal Year 2025 Results on May 6, 2025 SALT LAKE CITY, April 22, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its third quarter ended March 31, 2025, after the stock market closes on Tuesday, May 6, 2025. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day. Investors interested in partici...

 PRESS RELEASE

LifeVantage Expands Global Reach with International Launch of the MB S...

LifeVantage Expands Global Reach with International Launch of the MB System™ Following the highly successful launch in U.S. market, LifeVantage begins taking its groundbreaking MB System™ internationally SALT LAKE CITY, March 17, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, is extending its groundbreaking MindBody GLP-1 System™ to international markets. This expansion comes after a 49% year-over-year increase in fiscal Q2 revenue ending December 31, 2024, in the U.S., la...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch